Literature DB >> 9218462

Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. Relationship between its expression and activity.

A Paire1, F Bernier-Valentin, S Selmi-Ruby, B Rousset.   

Abstract

Anti-peptide antibodies directed against the C-terminal portion (amino acids 603-618) of the rat thyroid iodide transporter (rTIT) have been produced to characterize the molecular forms of rTIT in the rat thyroid and in the functional rat thyroid cell line, FRTL-5. rTIT is located on the basolateral membrane of rat thyroid follicular cells and randomly distributed on the plasma membrane of FRTL-5 cells that do not exhibit cell polarity. The major rTIT component corresponds to an 80-90-kDa glycosylated protein. After treatment of cell membrane fractions with N-glycosidase F or incubation of FRTL-5 cells with tunicamycin, rTIT has an apparent molecular mass of about 55 kDa. FRTL-5 cells cultured in the presence of TSH exhibit a high rTIT content and a high iodide uptake activity (IUA). Upon either removal of TSH or addition of cycloheximide, IUA declines more rapidly than rTIT. The half-life of rTIT was about 4 days. Re-exposure of 7-day TSH-deprived FRTL-5 cells to TSH causes a rapid synthesis of the glycosylated rTIT but a delayed re-induction of IUA. Tunicamycin totally prevents the TSH-dependent re-expression and activity of rTIT. Our data bring basic information on the location, structure, and turnover of rTIT and suggest that its activity is subjected to diverse control mechanisms including regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218462     DOI: 10.1074/jbc.272.29.18245

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

3.  Expression of sodium iodide symporter in benign and malignant human thyroid tissues.

Authors:  J D Lin; C Hsueh; T C Chao; H F Weng
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

4.  Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.

Authors:  T Saito; T Endo; A Kawaguchi; M Ikeda; R Katoh; A Kawaoi; A Muramatsu; T Onaya
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

5.  Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).

Authors:  Stephanie Sieger; Shiming Jiang; Frank Schönsiegel; Helmut Eskerski; Wolfgang Kübler; Annette Altmann; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-23       Impact factor: 9.236

6.  Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Authors:  S J Beyer; R E Jimenez; C L Shapiro; J Y Cho; S M Jhiang
Journal:  Breast Cancer Res Treat       Date:  2008-05-26       Impact factor: 4.872

7.  Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.

Authors:  Séverine Trouttet-Masson; Samia Selmi-Ruby; Françoise Bernier-Valentin; Valérie Porra; Nicole Berger-Dutrieux; Myriam Decaussin; Jean-Louis Peix; Agnès Perrin; Claire Bournaud; Jacques Orgiazzi; Françoise Borson-Chazot; Brigitte Franc; Bernard Rousset
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 8.  The Na+/I- symporter (NIS): recent advances.

Authors:  O Levy; A De la Vieja; N Carrasco
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

9.  The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription.

Authors:  M Ohno; M Zannini; O Levy; N Carrasco; R di Lauro
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

10.  Endotoxin-induced inflammation down-regulates L-type amino acid transporter 1 (LAT1) expression at the blood-brain barrier of male rats and mice.

Authors:  Gábor Wittmann; Petra Mohácsik; Mumtaz Yaseen Balkhi; Balázs Gereben; Ronald M Lechan
Journal:  Fluids Barriers CNS       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.